Category: Include on Menu
-
Moderna Extends Rally as FDA Advisory Panel Reviews Flu Vaccine Application (MRNA)
Moderna (NASDAQ:MRNA) shares moved higher on Thursday, building on the previous session’s strong gains as investors focused on a key review of the company’s influenza vaccine by a U.S. Food and Drug Administration advisory committee. The stock advanced 3% after surging 11.5% on Wednesday, with market attention centred on the regulatory outlook for the company’s…
-
Spero Shares Jump After FDA Clears First Oral Carbapenem Antibiotic for U.S. Market (SPRO)
Spero Therapeutics (NASDAQ:SPRO) shares climbed 16% on Thursday after the U.S. Food and Drug Administration approved Utebzi, a novel oral carbapenem antibiotic developed through a collaboration between GSK (NYSE:GSK) and Spero, for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis, in adults with limited or no suitable oral treatment alternatives. Landmark Approval Opens…
-
US Jobless Claims Ease Slightly as Labour Market Remains Stable
U.S. unemployment benefit applications edged lower last week, pointing to continued resilience in the labour market despite signs of a gradual cooling in hiring conditions. According to data released by the Labor Department on Thursday, initial jobless claims fell by 4,000 to 226,000 in the week ended June 13, compared with a revised 230,000 in…
-
Wall Street Set for Rebound as Iran Peace Accord Lifts Sentiment: Dow Jones, S&P, Nasdaq, Futures
U.S. stock futures pointed higher on Thursday, indicating a stronger start for Wall Street after equities sold off sharply following the Federal Reserve’s latest policy decision. Investor sentiment improved after the United States and Iran formally signed a preliminary agreement aimed at ending the conflict in the Middle East, easing concerns over energy supplies and…
-
Pfizer Shares Slip Following CFO Transition Announcement
Pfizer Inc. (NYSE:PFE) shares edged lower on Thursday after the pharmaceutical giant revealed that Chief Financial Officer Dave Denton will step down from his position and leave the company in August. The stock fell 1.7% after investors digested the leadership change, which comes as Pfizer continues to navigate a period of strategic transformation and integration…
-
FreeCast Soars After Securing Starlink Business Reseller Partnership
FreeCast Inc. (NASDAQ:CAST) shares skyrocketed 170% on Thursday after the company announced a reseller agreement that will allow it to offer Starlink Business satellite broadband services alongside its existing media and technology platform solutions. The deal significantly expands FreeCast’s addressable market by combining high-speed connectivity with digital content, advertising and streaming services under a single…
-
Novocure Shares Slide After Phase 3 Glioblastoma Study Falls Short of Survival Goal
Novocure (NASDAQ:NVCR) shares dropped 10% after the company reported that its Phase 3 TRIDENT trial failed to achieve its primary objective of demonstrating a statistically significant improvement in overall survival for patients with newly diagnosed glioblastoma. The results disappointed investors who had been looking for evidence that earlier use of the company’s Tumor Treating Fields…
-
Oklo and Centrus Advance Ohio Nuclear Project With Fuel Supply Agreement (OKLO)
Oklo Inc. (NYSE:OKLO) and Centrus Energy Corp. (AMEX:LEU) have taken a significant step toward supporting next-generation nuclear energy deployment in Ohio after signing a Letter of Intent covering the supply of high-assay low-enriched uranium (HALEU) for Oklo’s planned Aurora reactors. The agreement strengthens the fuel supply chain for advanced nuclear technology while supporting broader efforts…
-
Enphase Energy Climbs After Barclays Upgrade and New Product Rollout (ENPH)
Enphase Energy Inc (NASDAQ:ENPH) shares surged 6.7% in premarket trading on Thursday after receiving an analyst upgrade from Barclays and announcing the start of production shipments for a new commercial microinverter designed for large-scale solar installations. The combination of a more constructive outlook from Wall Street and progress in the company’s product pipeline helped lift…
-
HIVE Digital Rallies on $220 Million AI Infrastructure Agreement and Swedish Data Center Acquisition
HIVE Digital Technologies Ltd. (NASDAQ:HIVE) shares surged 11.8% in premarket trading on Thursday after the company announced a major GPU cloud computing contract worth approximately $220 million and revealed plans to acquire a data center in Sweden. The announcements mark a significant expansion of HIVE’s high-performance computing business as demand for artificial intelligence infrastructure continues…